Clinical Trial Update: OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating OPT-821 with or without vaccine therapy in ovarian, fallopian tube, or primary peritoneal cancer in second or third complete r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• OPT-821

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-09-06